# The Medical Devices (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 49: Insertion of regulation 8(4A)


After regulation 8(4) insert—
“(4A) In regulation 56 (fees payable in relation to clinical investigation notices), in paragraph (2), for “his authorised representative” substitute “their UK responsible person”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348214956/schedule/2/paragraph/49 (the official version)
Page: https://openlegislation.uk/draft-medical-devices-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-49
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.